We must address climate change, inequality, and poverty simultaneously, but prevailing economic approaches are failing; ...

A large California-based analysis found that reopening schools sharply reduced children’s diagnoses of anxiety, depression, and ADHD. Children who returned to in-person school during the COVID-19 ...

Holiday joy shouldn’t require perfection. Here's why stress spikes this season, what truly brings happiness, and how small ...

So, when group ritualized practices consistently deliver intense feelings—whether pleasure, acceptance, or meaning—your brain ...

Azacitidine-venetoclax showed superior event-free survival and overall response rates compared to traditional induction ...

The triplet regimen of azacitidine, venetoclax, and tagraxofusp showed high complete response rates in both untreated and relapsed/refractory BPDCN patients. Safety profile of the triplet was ...

Senate Minority Leader Chuck Schumer (D-NY) speaks at a press conference following recent elections as the government ...

School reopenings after COVID-19 closures significantly improved children's mental health, reducing diagnoses of depression, ...

By Will Seaton, Draftwise. Over the past 18 months, I’ve had countless conversations with partners, associates, and general counsel regarding AI in legal practice. The pattern is remarkably ...

The KOMET-007 trial demonstrated that ziftomenib combined with venetoclax and azacitidine was well-tolerated in relapsed/refractory AML patients with NPM1 mutations or KMT2A rearrangements. Common ...

Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate.

BOAS is a platform for building multivalent viral protein immunogens without a scaffold, such as a nanoparticle, to elicit broad influenza vaccine responses.